HomeFDMT • NASDAQ
4D Molecular Therapeutics Inc
Follow
$4.28
0.94%
Pre-market:(0.23%)-0.010
$4.27
Closed: Mar 14, 7:42:35 AM GMT-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 1.00K | 105.26% |
Operating expense | 13.03M | 22.88% |
Net income | -49.67M | -53.86% |
Net profit margin | -4.97M | -3,023.36% |
Earnings per share | -0.90 | -16.88% |
EBITDA | -55.02M | -54.77% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 424.88M | 47.41% |
Total assets | 560.38M | 64.87% |
Total liabilities | 49.78M | 55.26% |
Total equity | 510.61M | — |
Shares outstanding | 46.30M | — |
Price to book | 0.38 | — |
Return on assets | -24.10% | — |
Return on capital | -25.21% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -49.67M | -53.86% |
Cash from operations | -45.86M | -86.06% |
Cash from investing | 7.06M | 205.64% |
Cash from financing | 601.00K | -87.38% |
Net change in cash | -38.20M | -43.78% |
Free cash flow | -28.71M | -91.15% |
Previous close
$4.24
Day range
$4.17 - $4.40
Year range
$3.73 - $36.25
Market cap
197.85M USD
Avg Volume
927.75K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2013
Headquarters
Website
Employees
227
